Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.0K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.0K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

85
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
85
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

41
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
41
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

82
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
82
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

69
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
69
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

873
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
873

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of relationship between type of body shape assessed using waist-to-hip ratio, and occurrence of cardiovascular risk factors in patients with acute coronary syndrome.

Annals of agricultural and environmental medicine : AAEM·2026
Same author

Dietary supplement use for eye health in adults: knowledge, motivations, and consumption patterns in a nationwide sample of adults in Poland, 2026.

Frontiers in nutrition·2026
Same author

Beyond DSM Categories: Criteria for Biologically Valid Disease Axes in Psychiatry.

Journal of clinical medicine·2026
Same author

Vitamin D as a Lifespan Neuroimmune Signal in Psychiatry: From Developmental Risk to Precision Nutrition.

Nutrients·2026
Same author

The Dilution Paradox in Extracellular Vesicle Flow Cytometry.

Journal of extracellular vesicles·2026
Same author

Comparison of clinical characteristics, treatment, in-hospital and 12-month outcomes in patients after myocardial infarction with ejection fraction < 40% with or without atrial fibrillation.

Archives of medical science : AMS·2026

Related Experiment Video

Updated: Oct 30, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K

Statins in COVID-19 Therapy.

Justyna Olszewska-Parasiewicz1, Łukasz Szarpak2,3, Sylwester Rogula4

  • 1Central Clinical Hospital the Ministry of the Interior and Administration, Wołoska 137, 02-507 Warsaw, Poland.

Life (Basel, Switzerland)
|July 2, 2021
PubMed
Summary
This summary is machine-generated.

Statins, used for cardiovascular disease, may offer benefits in COVID-19 treatment due to their anti-inflammatory and anti-thrombotic effects. Continued statin use is recommended for COVID-19 patients with existing cardiovascular conditions.

Keywords:
COVID-19SARS-CoV-2pleiotropic effectsstatinstherapy

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.7K
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.0K

Related Experiment Videos

Last Updated: Oct 30, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.7K
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.0K

Area of Science:

  • Cardiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Statins (3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors) are widely used for cardiovascular disease prevention and treatment.
  • Statins possess pleiotropic effects, including antioxidant, anti-inflammatory, and endothelial function improvement.
  • COVID-19 is associated with endothelial dysfunction, thrombosis, and a cytokine storm, conditions potentially mitigated by statins.

Purpose of the Study:

  • To review the pathophysiology of SARS-CoV-2 infection.
  • To examine the proposed therapies for COVID-19.
  • To evaluate the potential role of statins as adjuvant therapy in COVID-19, considering their pleiotropic activities.

Main Methods:

  • Review of recent scientific literature on SARS-CoV-2 pathophysiology.
  • Analysis of proposed COVID-19 therapeutic strategies.
  • Examination of studies on statins' pleiotropic effects.
  • Review of clinical trials involving statins in respiratory infections.

Main Results:

  • Statins' pleiotropic properties may be beneficial in managing COVID-19 complications like endothelial dysfunction and thrombosis.
  • Current guidelines recommend continuing statin therapy for cardiovascular patients with COVID-19.
  • Initiating statin therapy solely for COVID-19 treatment is advised only within clinical trials.

Conclusions:

  • Statins may have a role as adjuvant therapy in COVID-19 due to their multifaceted benefits.
  • Continuation of statin therapy is supported for existing cardiovascular patients diagnosed with COVID-19.
  • Further clinical investigation is warranted for de novo statin initiation in COVID-19 management.